Domestic companies predict a 16% growth in the South Korean pharma market
CPHI onsite survey highlights emerging trends in 2017 for South Korean pharma.
CPHI Korea, organized by UBM, closed its doors in Seoul after another record-breaking event that attracted 4,300 attendees and 147 exhibitors. During the event, UBM undertook an in-depth onsite survey of both international and domestic attendees, with domestic companies reporting a headline growth in the order of 16% across the South Korean pharma economy.
As the largest pharma event in South Korea, the confidence amongst the attendees is a good indication of the industry’s overall health. And, the onsite survey results showed that 75% of domestic companies believe that the South Korean biologics and biosimilars sectors will grow the fastest’. However, just 44.5% of international companies agreed with this, with 30% stating generics had the biggest potential.
Highlighting the positive impact the Incheon Free Economic Zone has had on the industry, 95% of all respondents backed the government introducing ‘further similar incentives’. International respondents were also complimentary of government initiatives to position the country as a biotech leader. Over 85% of them agreed that Bio-Vision 2016 had been very successful and made good strides in achieving the goal of becoming a trusted market frontrunner’. Conversely, a diametric result was observed domestically as only 33% of respondents saw the initiative as a success.
“CPHI Korea reflects this booming pharma economy and the event provided an on-the-ground view of the changes in the market. In particular, a higher demand for biologics products and high growth in the biosimilars sector is now complementing South Korean pharma’s strength in innovative products, with generics also showing promising growth,” commented Laura Murina, CPHI Korea Brand Manager.
International partnerships are quickly becoming a driving force for South Korea’s pharma sector. Highlighting this, over 95% of the international companies surveyed, reported they are looking to work with South Korean partners in the next year, and 43% of domestic respondents have undertaken work in international markets.
“CPHI Korea provides the international pharma community with a vast array of opportunities within the domestic market and there has been a visible shift towards South Korean companies starting to work together with the international industry at the event”, added Laura Murina.
The complete report and analysis will be available later on in the year on the CPHI Pharma Insights website.
One attendee from XEMED added: “This was our first time attending CPhl Korea and it was a wonderful opportunity for our company XEMED to meet with potential partners from Korea and India. We will definitely be attending again next year.”
Related News
-
News Pharmapack Awards 2024 Patient-Centric Design Award Winner – Dr Ferrer BioPharma
The 2024 Pharmapack Awards celebrated the best in innovation and design for the pharmaceutical packaging and drug delivery industry on January 24, 2024. -
News Women in Pharma: Minding the Gap at Pharmapack 2024
2024 marks the first year Pharmapack will host a Diversity track dedicated to bridging the gap within the pharmaceutical packaging and drug delivery sector. The track includes a panel discussion on 'Enabling Diversity in the Workplace,' focused... -
News Pharmapack Awards 2024 - Celebrating Packaging and Drug Delivery Innovation
The 2024 Pharmapack Innovation Awards ceremony celebrated the best in pharmaceutical packaging and drug delivery innovation at all levels. The awards were held on January 24, 2024 at the Paris Expo Porte de Versailles. -
News Pharmapack 2024 - From the Floor
Paris once again welcomes Europe’s leading trade show in pharmaceutical packaging and drug delivery innovation. Join our content team as Pharmapack 2024 opens its doors to leading experts and innovators in pharmaceutical packaging and drug delive... -
News CPHI Barcelona 2023: Partnering for Success – Managing Outsourcing Relationships to Optimise Manufacturing Operations
During CPHI Barcelona 2023, insightful content sessions offered attendees the chance to explore trending topics with expert speakers and panellists. Here, we summarise what the pharma industry and supply chain are talking about the most. -
News CPHI Barcelona 2023: Loading Potential – Artificial Intelligence for Pharma Manufacturing
During CPHI Barcelona 2023, insightful content sessions offered attendees the chance to explore trending topics with expert speakers and panellists. Here, we summarise what the pharma industry and supply chain are talking about the most. -
News Pharmaceutical industry supports COP28 health stance in joint statement
As COP28 takes place over this week in Dubai, UAE, several bodies in the pharmaceutical and health industries have come together to announce support of key movements in sustainability in the sector, and to recognise sustainability as a health issue.&nb... -
News CPHI Podcast Series: Start-ups take centre stage at CPHI Barcelona
The first episode of the CPHI Podcast Series since we attended CPHI Barcelona in October covers the Start-up market at the event, with expert Matthew Wise joining Editor Lucy Chard to discuss the event.
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance